New Device Monitors Diseases Through Sweat
Researchers created a flexible sweat-monitoring device that induces sweat through drug stimulation, enabling non-invasive health monitoring.
Read MorePosted by Andy Lundin | May 28, 2024 | Diagnostic Technologies |
Researchers created a flexible sweat-monitoring device that induces sweat through drug stimulation, enabling non-invasive health monitoring.
Read MorePosted by Andy Lundin | May 24, 2024 | Colorectal |
The FDA’s Medical Devices Advisory Committee recommended approval of Guardant Health’s Shield blood test for colorectal cancer screening.
Read MorePosted by Andy Lundin | May 22, 2024 | Cardiovascular |
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MorePosted by Andy Lundin | May 21, 2024 | Sequencing Systems |
Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.
Read MorePosted by Andy Lundin | May 14, 2024 | Covid 19 |
The FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read More